{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective from the specified list.", "method": "llm_batch", "batch_id": "batch_1_16748", "batch_size": 200, "batch_pos": 173, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "No high-potency verb, potent metaphor, superlative + harm noun, intensifier + harm noun, or critical alert phrase found.", "method": "llm_batch", "batch_id": "batch_2_18128", "batch_size": 200, "batch_pos": 134, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment describes a future plan ('would begin'), not realised impact.", "method": "llm_batch", "batch_id": "batch_3_14304", "batch_size": 200, "batch_pos": 67, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "Segment contains no question.", "method": "llm_batch", "batch_id": "batch_4_13908", "batch_size": 200, "batch_pos": 61, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment describes testing timeline but contains no explicit calming cues.", "method": "llm_batch", "batch_id": "batch_5_14052", "batch_size": 200, "batch_pos": 55, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "Segment does not contain a minimiser + scale contrast.", "method": "llm_batch", "batch_id": "batch_6_15924", "batch_size": 200, "batch_pos": 5, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_20824", "batch_size": 200, "batch_pos": 199, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "Describes a future plan for testing ('late-stage testing would begin in 2025').", "method": "llm_batch", "batch_id": "batch_8_9072", "batch_size": 200, "batch_pos": 10, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
